R. A. Oseshnyuk
Limited Liability Company “Eco-Safety Scientific Research Center”
Russian Federation

Principal Investigator, Deputy Manager of Eco-Safety Scientific Research Center.

65, Yuri Gagarin Ave., St. Petersburg, Russia, 196143

A. G. Nikiforova
Limited Liability Company “Exacte Labs”
Russian Federation

head of the Bioanalytics Department of Exacte Labs. 

Bldg 2, 20, Nauchny driveway, Moscow, Russia, 117246

A. Yu. Boroduleva
Limited Liability Company “Exacte Labs”
Russian Federation

Senior Analytical Chemist of Exacte Labs. 

Bldg 2, 20, Nauchny driveway, Moscow, Russia, 117246

P. D. Sobolev
Limited Liability Company “Exacte Labs”
Russian Federation

head of the laboratory of bioanalytics of Exacte Labs. 

Bldg 2, 20, Nauchny driveway, Moscow, Russia, 117246

S. A. Lesnichuk
First Moscow State Medical University (Sechenov University)
Russian Federation

Candidate of Sciences (Biology), Associate Professor of the Biological Chemistry Department, First Moscow State Medical University.

Bldg 2, 8, Trubetskaya Str., Moscow, Russia, 119991

B. B. Garyaev
First Moscow State Medical University (Sechenov University)
Russian Federation

4^th year student of the Institute of Pharmacy n. a. A.P. Nelyubina, First Moscow State Medical University.

Bldg 2, 8, Trubetskaya Str., Moscow, Russia, 119991

A. A. Abramova
Peoples’ Friendship University of Russia
Russian Federation

post-graduate student of Peoples’ Friendship University of Russia. 

21, Bryusov driveway, Moscow, Russia, 125009

V. G. Mozgovaya
Joint-Stock Company “R-Pharm”
Russian Federation

Scientific Advisor of the preclinical and Clinical Development Department, R-Pharm group. 

Bldg 1, 19, Berzarin Str., Moscow, Russia, 123154

O. V. Filon
Joint-Stock Company “R-Pharm”
Russian Federation

Director of the Department of preclinical and Clinical Development, R-Pharm group. 

Bldg 1, 19, Berzarin Str., Moscow, Russia, 123154

A. V. Zinkovskaya
Joint-Stock Company “R-Pharm”
Russian Federation

head of the Biostatistics Group of the preclinical and Clinical Development Department, R-Pharm group.

Bldg 1, 19, Berzarin Str., Moscow, Russia, 123154

A. N. Dolgorukova
Joint-Stock Company “R-Pharm”
Russian Federation

biostatistician of the of preclinical and Clinical Development Department, R-Pharm group. 

Bldg 1, 19, Berzarin Str., Moscow, Russia, 123154

E. K. Khanonina
1. First Moscow State Medical University (Sechenov University). 2. Joint-Stock Company “R-Pharm”
Russian Federation

Medical Writer of the Preclinical and Clinical Development Department, R-Pharm group; 2th year student of the Institute of Pharmacy n. a. A.P. Nelyubina, First Moscow State Medical University.

Bldg 2, 8, Trubetskaya Str., Moscow, Russia, 119991.

Bldg 1, 19, Berzarin Str., Moscow, Russia, 123154

V. G. Ignatiev
Joint-Stock Company “R-Pharm”
Russian Federation

Candidate of Sciences (Medicine), General Director of R-Pharm group. 

Bldg 1, 19, Berzarin Str., Moscow, Russia, 123154

M. Yu. Samsonov
Joint-Stock Company “R-Pharm”
Russian Federation

Candidate of Sciences (Medicine), Associate Professor, Medical Director, R-Pharm group. 

Bldg 1, 19, Berzarin Str., Moscow, Russia, 123154